In this article, Chief Editor Tom von Gunden explains why he sees 2026 as the year combination products and therapies become fully central to drug and biologics product development, delivery, and regulatory. He points to personalized medicine and patient self-administration as key factors shaping his view of the drug delivery landscape.
- Regulating For Patient Safety And Success With Combination Products
- FDA Issues Final Guidance For pH Adjuster Waiver Requests For Generic Drugs
- Strained Manufacturing, Complexity Stymie In Vivo Progress
- To Fight Cancer, Gene Editing Needs To Solve Its Delivery Problem
- Is Oncology Precision Medicine Coming of Age?
- Drug Delivery Trends From 2025: Top 4 For Momentum Gains In 2026
- The Blue Crayfish: Turning Nature's Efficiency Into Safe, Bioavailable Therapeutics
- Formulation And Delivery Considerations For Cell And Gene Therapies
ON-DEMAND WEBINARS
High concentration formulations often present challenges with regard to viscosity as well as potential changes in the behavior upon stability. Discover solutions to mitigate high viscosity.
Explore primary packaging developed following well-established ICH principles for sustainable compliance and vial container closure systems for product development and commercial manufacturing needs.
Developing new delivery routes is essential for creating more effective treatments. Nanoforming enables new routes to simplify dosing, enhance patient comfort, and reduce healthcare costs.
Discover how pharma companies can select tailored pre-filled syringes for biologics and biosimilars by aligning drug delivery needs with specialized containers and analytical services.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1291031560-lab-research-computer]( "Approach To Improve Solubility And Bioavailability: Spray Drying")
Approach To Improve Solubility And Bioavailability: Spray DryingSpray dryers today support the development of some of the most advanced drug formulations, meeting the most precise morphological requirements to ensure performance, stability, and manufacturability.
-
![GettyImages-1321279050-inhaler-inhalation-breathe-lungs]( "Six Inhaler Sustainability Myths – And Why They Must Be Busted")
Six Inhaler Sustainability Myths – And Why They Must Be BustedThe solution to the carbon footprint of respiratory disease is complicated. The prevailing “myths” must be examined and addressed to achieve the shared industry vision of a decarbonized inhaler market.
-
![West-Vials Glamour V9]( "Long-Term Container Closure Integrity Testing Of Vial-Stopper-Seal Combinations")
Long-Term Container Closure Integrity Testing Of Vial-Stopper-Seal CombinationsThe study was designed to investigate CCI over a period of 24 months at ambient, ultra-low and cryogenic temperatures for serum-stopper samples and at ambient temperature for lyo-stopper samples.
-
![image1]( "The Importance Of An Analytical Testing Strategy")
The Importance Of An Analytical Testing StrategyA proper and well-thought-out combination product testing strategy, rooted in applicable guidances in sync with scientifically sound methods, data capture, and reporting and retainment, is critical.
-
![GettyImages-1002000796-lab-research-scientist-development]( "Functional Testing Summary Of Daikyo Crystal Zenith Nested Vials")
Functional Testing Summary Of Daikyo Crystal Zenith Nested VialsThe Daikyo Crystal Zenith nested vials meet the exterior dimensions of the glass standard ISO 8362-1. The vials maintain CCI for up to 6 months and can withstand ultra-cold temperatures and drop conditions.
-
![GettyImages-597935610 cell and gene]( "A Continuous Electroporation System For Viral Gene Therapy")
A Continuous Electroporation System For Viral Gene TherapyExplore the development work involved for the individual technologies that make up an innovative and scalable, chemical-free continuous viral vector production platform.
-
![ArQ-Bios-REGISTERED]( "Combining Human Needs With High Viscosity Formulations")
Combining Human Needs With High Viscosity FormulationsExplore the requirements of designing an autoinjector capable of handling the high pressures necessary for the delivery of highly viscous drug formulations with minimal impact on the patient.
-
![GettyImages-1302254900_nasal anatomy]( "White Paper: Nasal Delivery Of Spray Dried Biologics: Opportunities And Challenges")
White Paper: Nasal Delivery Of Spray Dried Biologics: Opportunities And ChallengesExplore the potential of spray-dried nasal formulations for biologics to achieve excellent stability and targeted delivery, paving the way for innovative and effective therapeutic solutions.
-
![StavanatoGroup-Vertiva On-Body Delivery System]( "Expanding Home-Based Care With A Next-Gen On-Body Delivery System")
Expanding Home-Based Care With A Next-Gen On-Body Delivery SystemAs on-body delivery systems (OBDSs) enable the shift to patient-centric treatment, manufacturers must optimize the device and therapy formulation to minimize the risks and increase adherence.
-
![BD Medical-1]( "Gliding Towards De-Risked Combination Product Development")
Gliding Towards De-Risked Combination Product DevelopmentLearn about the critical role plunger stoppers play in determining a combination drug product's exposure to extractables and leachables.
TOM'S TAKES ON DRUG DELIVERY
TALKING WITH TOM VIDEOCASTS
Fran offers keen industry and technical insights exclusively on Drug Delivery Leader.
DELIVERED BY DEGRAZIO
FREE EBOOK: COMBINATION PRODUCTS
Combination products provide significant avenues for increasing patient adherence and overall efficacy. This collection outlines the opportunity and identifies strategies for gaining regulatory approval.
